3-183015467-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020166.5(MCCC1):​c.2149G>A​(p.Glu717Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000843 in 1,614,144 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00046 ( 4 hom. )

Consequence

MCCC1
NM_020166.5 missense

Scores

1
7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.95

Publications

6 publications found
Variant links:
Genes affected
MCCC1 (HGNC:6936): (methylcrotonyl-CoA carboxylase subunit 1) This gene encodes the large subunit of 3-methylcrotonyl-CoA carboxylase. This enzyme functions as a heterodimer and catalyzes the carboxylation of 3-methylcrotonyl-CoA to form 3-methylglutaconyl-CoA. Mutations in this gene are associated with 3-Methylcrotonylglycinuria, an autosomal recessive disorder of leucine catabolism. [provided by RefSeq, Jul 2008]
MCCC1 Gene-Disease associations (from GenCC):
  • 3-methylcrotonyl-CoA carboxylase 1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • 3-methylcrotonyl-CoA carboxylase deficiency
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005342722).
BP6
Variant 3-183015467-C-T is Benign according to our data. Variant chr3-183015467-C-T is described in ClinVar as [Benign]. Clinvar id is 138181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00454 (692/152292) while in subpopulation AFR AF = 0.0159 (661/41558). AF 95% confidence interval is 0.0149. There are 3 homozygotes in GnomAd4. There are 331 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCCC1NM_020166.5 linkc.2149G>A p.Glu717Lys missense_variant Exon 19 of 19 ENST00000265594.9 NP_064551.3 Q96RQ3A0A0S2Z693

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCCC1ENST00000265594.9 linkc.2149G>A p.Glu717Lys missense_variant Exon 19 of 19 1 NM_020166.5 ENSP00000265594.4 Q96RQ3

Frequencies

GnomAD3 genomes
AF:
0.00453
AC:
690
AN:
152174
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00113
AC:
282
AN:
250644
AF XY:
0.000767
show subpopulations
Gnomad AFR exome
AF:
0.0153
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000708
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000457
AC:
668
AN:
1461852
Hom.:
4
Cov.:
31
AF XY:
0.000381
AC XY:
277
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0159
AC:
533
AN:
33478
American (AMR)
AF:
0.000805
AC:
36
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000297
AC:
33
AN:
1111984
Other (OTH)
AF:
0.000977
AC:
59
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
38
75
113
150
188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00454
AC:
692
AN:
152292
Hom.:
3
Cov.:
32
AF XY:
0.00444
AC XY:
331
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0159
AC:
661
AN:
41558
American (AMR)
AF:
0.00124
AC:
19
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68036
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00177
Hom.:
5
Bravo
AF:
0.00520
ESP6500AA
AF:
0.0143
AC:
63
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00139
AC:
169
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 04, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Methylcrotonyl-CoA carboxylase deficiency Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

3-methylcrotonyl-CoA carboxylase 1 deficiency Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.33
T;T;T
Eigen
Uncertain
0.36
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.88
D;D;D
MetaRNN
Benign
0.0053
T;T;T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Uncertain
2.5
M;.;.
PhyloP100
6.0
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.3
N;N;.
REVEL
Uncertain
0.52
Sift
Benign
0.12
T;T;.
Sift4G
Benign
0.18
T;T;T
Polyphen
0.88
P;P;.
Vest4
0.54
MVP
0.99
MPC
0.15
ClinPred
0.024
T
GERP RS
5.4
Varity_R
0.11
gMVP
0.82
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35706839; hg19: chr3-182733255; API